Showing results (1081-1090 of 1,396) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|October 31, 2022
APOBEC Mutational Signatures in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 Inhibitors and Endocrine TherapySarah Sammons, Kira Raskina, Natalie Danziger, et al.
JCO Precision Oncology|October 31, 2022
Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine OncologyPatricia Martin-Romano, Laura Mezquita, Antoine Hollebecque, et al.
JCO Precision Oncology|September 28, 2022
Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease RelapseFrédéric Cailleux, Elisa Agostinetto, Matteo Lambertini, et al.
JCO Precision Oncology|August 31, 2022
Isolated MLH1 Loss by Immunohistochemistry Because of Benign Germline MLH1 PolymorphismsDustin E Bosch, Matthew M Yeh, Stephen J Salipante, et al.
JCO Precision Oncology|January 7, 2022
Genomic Alterations in Head and Neck Squamous Cell Carcinoma: Level of Evidence According to ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT)Grégoire Marret, Ivan Bièche, Célia Dupain, et al.
JCO Precision Oncology|January 7, 2022
Ethical and Analytic Challenges With Genomic Sequencing of Relapsed Hematologic Malignancies Following Allogeneic Hematopoietic Stem-Cell TransplantationBilal Marwa, Joerg Krueger, Elizabeth A Stephenson, et al.
JCO Precision Oncology|January 7, 2022
Different Fumarate Hydratase Gene Variants Are Associated With Distinct Cancer PhenotypesJunne Kamihara, Carrie Horton, Yuan Tian, et al.
JCO Precision Oncology|January 7, 2022
Clinical Efficacy of Olaparib in IDH1/IDH2-Mutant Mesenchymal SarcomasJoseph P Eder, Deborah B Doroshow, Khanh T Do, et al.
JCO Precision Oncology|January 10, 2022
Real-World Data From a Molecular Tumor Board: Improved Outcomes in Breast and Gynecologic Cancers Patients With Precision MedicineLindsey M Charo, Ramez N Eskander, Jason Sicklick, et al.
JCO Precision Oncology|May 7, 2019
Biological Validation of RNA Sequencing Data from Formalin-Fixed Paraffin-Embedded Primary MelanomasLawrence N Kwong, Mariana Petaccia De Macedo, Lauren Haydu, et al.
Pageof 140